Virologists at the KU Leuven Rega Institute have been working on two lines of SARS-CoV-2 research: searching for a vaccine to prevent infection, and testing existing drugs to see which one can reduce...
N95 respirators, which are widely worn by health care workers treating COVID-19 patients, and are designed to be used only once, can be decontaminated effectively and worn up to three times, according...
An increasingly common mutation of the novel coronavirus found in Europe, North America and parts of Asia may be more infectious but appears less deadly, according to a prominent infectious diseases doctor....
Barely three months ago, the anti-malarial drug that President Donald Trump touted seemed like such a sure bet against COVID-19 that Susanna Naggie had a tough time setting up a national clinical trial...
Swiss pharmaceuticals giant Novartis has decided to halt a clinical trial of hydroxychloroquine as a treatment for COVID-19, citing problems in recruiting enough patients for the study of the controversial...
Anti-malaria drug hydroxychloroquine taken by Trump does NOT protect people from developing COVID-19 after they have been exposed to someone with the illness, study finds
Researchers gave hydroxychloroquine...
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok